BAG6 and B-cell chronic lymphocytic leukemia: On the other hand, while the NKp30 ligand soluble BAG6, released by lymphocytic leukemia cells, works as an inhibitory ligand of NKp30, exosome-bound BAG6 activates NK cells in chronic lymphocytic leukemia (CLL) [79].